Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Safety and acceptability of clozapine and risperidone in progressive multiple sclerosis: a phase 1, randomized, blinded, placebo-controlled trial

View ORCID ProfileAnne Camille La Flamme, David Abernethy, Dalice Sim, Liz Goode, Michelle Lockhart, David Bourke, Imogen Milner, Toni-Marie Garrill, Purwa Joshi, Eloise Watson, Duncan Smyth, Sean Lance, Bronwen Connor
doi: https://doi.org/10.1101/2020.03.12.20034983
Anne Camille La Flamme
1School of Biological Sciences, Victoria University of Wellington, Wellington New Zealand
2Malaghan Institute of Medical Research, Wellington, New Zealand
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anne Camille La Flamme
  • For correspondence: anne.laflamme{at}vuw.ac.nz
David Abernethy
3Neurology Department, Wellington Regional Hospital, Wellington, New Zealand
FRACP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dalice Sim
4Biostatistical Consulting Group, University of Otago, Wellington, New Zealand
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liz Goode
3Neurology Department, Wellington Regional Hospital, Wellington, New Zealand
BN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michelle Lockhart
5Pharmaceuticol Ltd, Auckland, New Zealand
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Bourke
3Neurology Department, Wellington Regional Hospital, Wellington, New Zealand
FRACP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Imogen Milner
3Neurology Department, Wellington Regional Hospital, Wellington, New Zealand
RN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toni-Marie Garrill
3Neurology Department, Wellington Regional Hospital, Wellington, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Purwa Joshi
3Neurology Department, Wellington Regional Hospital, Wellington, New Zealand
FRACP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eloise Watson
3Neurology Department, Wellington Regional Hospital, Wellington, New Zealand
RACP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Duncan Smyth
3Neurology Department, Wellington Regional Hospital, Wellington, New Zealand
FRACP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sean Lance
3Neurology Department, Wellington Regional Hospital, Wellington, New Zealand
RACP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bronwen Connor
6Department of Pharmacology and Clinical Pharmacology, Centre for Brain Research, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Data Availability

Deidentified data collected during this study and presented in this manuscript are available from the corresponding author on request from individuals affiliated with research or health care institutions.

Back to top
PreviousNext
Posted March 16, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Safety and acceptability of clozapine and risperidone in progressive multiple sclerosis: a phase 1, randomized, blinded, placebo-controlled trial
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Safety and acceptability of clozapine and risperidone in progressive multiple sclerosis: a phase 1, randomized, blinded, placebo-controlled trial
Anne Camille La Flamme, David Abernethy, Dalice Sim, Liz Goode, Michelle Lockhart, David Bourke, Imogen Milner, Toni-Marie Garrill, Purwa Joshi, Eloise Watson, Duncan Smyth, Sean Lance, Bronwen Connor
medRxiv 2020.03.12.20034983; doi: https://doi.org/10.1101/2020.03.12.20034983
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Safety and acceptability of clozapine and risperidone in progressive multiple sclerosis: a phase 1, randomized, blinded, placebo-controlled trial
Anne Camille La Flamme, David Abernethy, Dalice Sim, Liz Goode, Michelle Lockhart, David Bourke, Imogen Milner, Toni-Marie Garrill, Purwa Joshi, Eloise Watson, Duncan Smyth, Sean Lance, Bronwen Connor
medRxiv 2020.03.12.20034983; doi: https://doi.org/10.1101/2020.03.12.20034983

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Neurology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)